Clinical pharmacogenetics implementation consortium guideline (CPIC) for <i>CYP2D6</i> and <i>CYP2C19</i> genotypes and dosing of tricyclic antidepressants: 2016 update

  • JK Hicks
    DeBartolo Family Personalized Medicine Institute Division of Population Science, H. Lee Moffitt Cancer Center and Research Institute Tampa Florida USA
  • K Sangkuhl
    Department of Genetics Stanford University Stanford California USA
  • JJ Swen
    Department of Clinical Pharmacy and Toxicology Leiden University Medical Center Leiden The Netherlands
  • VL Ellingrod
    Department of Clinical, Social and Administrative Sciences College of Pharmacy, and Department of Psychiatry, School of Medicine, University of Michigan Ann Arbor Michigan USA
  • DJ Müller
    Campbell Family Mental Health Research Institute Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto Toronto Ontario Canada
  • K Shimoda
    Department of Psychiatry Dokkyo Medical University Japan
  • JR Bishop
    Department of Experimental and Clinical Pharmacology College of Pharmacy, and Department of Psychiatry, College of Medicine, University of Minnesota Minneapolis Minnesota USA
  • ED Kharasch
    Division of Clinical and Translational Research, Department of Anesthesiology Washington University in St Louis, St Louis Missouri USA
  • TC Skaar
    Division of Clinical Pharmacology, Department of Medicine Indiana University School of Medicine Indianapolis Indiana USA
  • A Gaedigk
    Division of Clinical Pharmacology Toxicology & Therapeutic Innovation, Children's Mercy, Kansas City, Missouri and Department of Pediatrics, University of Missouri‐Kansas City Kansas City Missouri USA
  • HM Dunnenberger
    Center for Molecular Medicine NorthShore University HealthSystem Evanston Illinois USA
  • TE Klein
    Department of Genetics Stanford University Stanford California USA
  • KE Caudle
    Department of Pharmaceutical Sciences St. Jude Children's Research Hospital Memphis Tennessee USA
  • JC Stingl
    Division of Research Federal Institute of Drugs and Medical Devices Bonn Germany

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ